The conference organized by Société Française de Biotechnologie will be held on November 5, 2018 in Paris, France.

Agnès Gouble, Preclinical Director, to take part in this event with a presentation entitled "Gene-edited allogeneic CAR T-cells (UCART) for cancer immunotherapy".